Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and effects of treatment
Brain and Development2008Vol. 31(1), pp. 46–51
Citations Over TimeTop 10% of 2008 papers
Teresa Temudo, M. Rios, C. Prior, Inês Carrilho, Mònica Santos, Patrı́cia Maciel, Jorge Sequeiros, Maria José Fonseca, João Monteiro, Pedro Cabral, José Pedro Vieira, Aída Ormazábal, Rafael Artuch
Abstract
Our results support that folinic acid supplementation has no significant effects on the course of the disease. We report discrete and novel neurotransmitter abnormalities that may contribute to the pathogenesis of RD highlighting the need for further studies on CSF neurotransmitters in clinically and genetically well characterized patients.
Related Papers
- → A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome(2001)1,559 cited
- → MeCP2 Dysfunction in Humans and Mice(2005)90 cited
- → Rett syndrome: what do we know for sure?(2009)28 cited
- → Ocular MECP2 Protein Expression in Patients With and Without Rett Syndrome(2010)17 cited
- → Can we relate MeCP2 deficiency to the structural and chemical abnormalities in the Rett brain?(2005)18 cited